AAAAAA

   
Results: 1-3 |
Results: 3
Treatment of systemic mast-cell disease with cladribine
Authors: Tefferi, A Li, CY Butterfield, JH Hoagland, HC
Citation: A. Tefferi et al., Treatment of systemic mast-cell disease with cladribine, N ENG J MED, 344(4), 2001, pp. 307-309
A long-term retrospective study of young women with essential thrombocythemia
Authors: Tefferi, A Fonseca, R Pereira, DL Hoagland, HC
Citation: A. Tefferi et al., A long-term retrospective study of young women with essential thrombocythemia, MAYO CLIN P, 76(1), 2001, pp. 22-28
A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia
Authors: Mesa, RA Tefferi, A Elliott, MA Hoagland, HC Call, TG Schroeder, GS Yoon, SY Li, CY Gray, LA Margolin, S Hook, CC
Citation: Ra. Mesa et al., A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia, BR J HAEM, 114(1), 2001, pp. 111-113
Risultati: 1-3 |